-

Marsh McLennan’s Oliver Wyman to Acquire Healthcare Analytics Business Validate Health

NEW YORK--(BUSINESS WIRE)--Oliver Wyman, a global leader in management consulting and a business of Marsh McLennan (NYSE: MMC), today announced an agreement to acquire Validate Health, a healthcare analytics business that enables healthcare providers and Accountable Care Organizations (ACOs) to better manage costs, risk, and performance. The terms of the transaction, expected to close in summer 2025, were not disclosed.

Validate Health will join Oliver Wyman Actuarial, a specialized business within Oliver Wyman that provides actuarial services to insurers, investors, healthcare providers, corporates and other clients. The acquisition strengthens the business through powerful analytic and technology solutions that help clients grow market size, increase margins, optimize programs, manage risk, and secure investments and funding, while also enhancing patient outcomes.

“Healthcare is a complex and critical industry featuring a unique set of challenges, and it is undergoing a seismic shift,” said David Weinsier, Partner, Global Life and Health Leader for Oliver Wyman Actuarial. “This acquisition allows us to not only meet that moment but lead it. By combining our deep actuarial and policy expertise with Validate Health’s data-driven solutions, we are at the forefront of building an analytics platform that helps clients improve healthcare delivery and drive efficiency.”

Andrew Webster, Validate Health Co-Founder, added, “This is a milestone moment for us. From the start, our mission has been to make healthcare better through data. Joining forces with Oliver Wyman gives us the reach, actuarial and insurance expertise, and complementary skillsets to supercharge that mission. Our clients – and their patients – stand to gain the most.”

For more information about Oliver Wyman Actuarial services, visit our Actuarial Consulting website.

About Oliver Wyman

Oliver Wyman, a business of Marsh McLennan (NYSE: MMC), is a management consulting firm combining deep industry knowledge with specialized expertise to help clients optimize their business, improve operations and accelerate performance. Marsh McLennan is a global leader in risk, strategy and people, advising clients in 130 countries across four businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman. With annual revenue of over $24 billion and more than 90,000 colleagues, Marsh McLennan helps build the confidence to thrive through the power of perspective. For more information, visit marshmclennan.com, follow us on LinkedIn and X.

About Validate Health

Validate Health provides ongoing actuarial and financial optimization services customized for Accountable Care Organizations (ACOs). It reconstructs the Centers for Medicare and Medicaid Services (CMS) methodology using computer models for MSSP, REACH, Medicare Advantage, and other accountable care programs. Depending on the decision needed, Validate Health simulates the impact of multiple scenarios at different organizational levels, time horizons, and decision frequencies.

Contacts

Danielle Arceneaux
1 (212) 345 0198
danielle.arceneaux@mmc.com

Oliver Wyman

NYSE:MMC

Release Versions

Contacts

Danielle Arceneaux
1 (212) 345 0198
danielle.arceneaux@mmc.com

More News From Oliver Wyman

New report from Oliver Wyman and Association of Equipment Manufacturers finds rising uncertainty is reshaping equipment manufacturing

NEW YORK--(BUSINESS WIRE)--Oliver Wyman, a global leader in management consulting and a business of Marsh McLennan (NYSE:MMC), and the Association of Equipment Manufacturers (AEM) today unveiled findings from a joint study on the state of the North America’s industrial goods sector, focusing on construction and agricultural manufacturing. The State of the Industrial Goods North America, Non-Road Edition, reveals declining sentiment among equipment manufacturers in the face of tariff unpredictab...

Oliver Wyman announces newly elected Partners and Executive Directors for 2026

NEW YORK--(BUSINESS WIRE)--Oliver Wyman, a global leader in management consulting and a business of Marsh McLennan (NYSE:MMC), today announced 40 newly elected Partners and four newly elected Executive Directors for 2026. "This exceptional group includes leaders who have consistently delivered for our clients while strengthening the collaborative spirit that defines our success,” said Nick Studer, CEO of Oliver Wyman Group. “They exemplify what we can achieve when we operate as one, and I am co...

Supply Chain Challenges Could Cost Airlines More Than $11 Billion in 2025

NEW YORK--(BUSINESS WIRE)--Oliver Wyman, a global leader in management consulting and a business of Marsh McLennan (NYSE:MMC), today launched a joint study in collaboration with the International Air Transport Association (IATA). The report, Reviving the Commercial Aircraft Supply Chain, addresses supply chain challenges in the aerospace industry, and explores the root cause of these challenges, the impact on airlines, and initiatives to move the aviation industry forward. Challenges within the...
Back to Newsroom